Ziprasidone in the treatment of borderline personality disorder: A double-blind, placebo-controlled, randomized study.
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2008
At a glance
- Drugs Ziprasidone (Primary)
- Indications Borderline personality disorders
- Focus Therapeutic Use
- 03 Apr 2008 New trial record.
- 11 Mar 2008 Last checked against ClinicalTrials.gov record.